Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
| Brand name | MINOCYCLINE HYDROCHLORIDE |
| Generic name | MINOCYCLINE HYDROCHLORIDE |
| Active ingredient(s) | MINOCYCLINE HYDROCHLORIDE |
| Distributed by / for | Ascend Laboratories, LLC, Parsippany, NJ 07054 |
| NDC | 67877-644-30 |
| Full product label | Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30 |
| Recalling firm | Ascend Laboratories, LLC |
| Distribution | Nationwide in the USA |
| Quantity | 360 30-count bottles |
| Recall initiated | 2026-06-01 |
| Report date | 2026-06-17 |
| Recall completed | — |
| Recall number | D-0597-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bedminster NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗